CD20 monoclonal antibodies

CD20 monoclonal antibodies are a type of targeted therapy used mainly to treat certain blood cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. They work by specifically recognizing and binding to a protein called CD20 found on the surface of B-cells, which are a type of immune cell. By attaching to these cells, the antibodies mark them for destruction by the immune system or trigger a process that leads to their elimination. This approach helps to reduce cancer cells while sparing most healthy cells, making it a more precise treatment option compared to traditional chemotherapy.